Hyphens Pharma to expand footprint in South-east Asia: CEO

SINGAPORE’S leading specialty pharmaceutical and consumer healthcare group, Hyphens Pharma International, is expanding its South-east Asia footprint beyond the five countries that it is already in, said its chairman and chief executive officer Lim See Wah.

He told The Business Times that Hyphens Pharma intends to set up offices in countries where it does not have any presence to capture the region’s demand growth, underpinned by its demography and economic development. 

“The immediate aspiration is how we can become an Asean pharmaceutical and consumer healthcare company. Today, we are already present in five of the 10 markets. Outside Asean, we will have to be a lot more cautious when it comes to building presence.”